- B2B
- Early StageStartup in initial stages
Parker Isaac careers
Pathology labs in the US process 75 million tissue samples each year, all of which are manually prepared for diagnosis using basic tools, like a scalpel and cutting board.
High case volumes force clinicians to compromise. They simply don’t have time to prepare and examine entire samples, so they settle for portions that they hope are representative.
If critical diagnostic tissue is missed, then the diagnosis will be inaccurate. For colorectal cancer, our initial focus, up to 30% of stage II patients receive a misdiagnosis and risk not receiving the treatment that they need.
We're first to market with an automated device that prepares complete cancer samples for diagnosis - it's called the Adipress.
The Adipress is fast and easy to use. Run time is 60 seconds. In contrast, clinicians typically spend an hour manually preparing a representative section. The Adipress is comprehensive. For the first time, clinicians can efficiently submit all available tissue for diagnosis.
Our technology is registered with the FDA as a class 1 medical device and is protected by two issued US patents and a pending PCT application in Europe.
Most importantly, the Adipress works. Using the Adipress, clinicians have uncovered additional cancer positive tissue, revealing a more advanced disease.
Join us to modernize tissue preparation for cancer treatment.
High case volumes force clinicians to compromise. They simply don’t have time to prepare and examine entire samples, so they settle for portions that they hope are representative.
If critical diagnostic tissue is missed, then the diagnosis will be inaccurate. For colorectal cancer, our initial focus, up to 30% of stage II patients receive a misdiagnosis and risk not receiving the treatment that they need.
We're first to market with an automated device that prepares complete cancer samples for diagnosis - it's called the Adipress.
The Adipress is fast and easy to use. Run time is 60 seconds. In contrast, clinicians typically spend an hour manually preparing a representative section. The Adipress is comprehensive. For the first time, clinicians can efficiently submit all available tissue for diagnosis.
Our technology is registered with the FDA as a class 1 medical device and is protected by two issued US patents and a pending PCT application in Europe.
Most importantly, the Adipress works. Using the Adipress, clinicians have uncovered additional cancer positive tissue, revealing a more advanced disease.
Join us to modernize tissue preparation for cancer treatment.
Parker Isaac hasn't added any jobs yet
Get notified when Parker Isaac posts new jobs.
Alex Bodell
Founder Parker Isaac Instruments, mechanical engineer, product development, domestic & international manufacturing.
Valuation
$5M
Funded over
6 rounds
Latest round
Pre-Seed (Dec 2019)
Veebot • Omaha • 4 days ago
axogen • Florida • $69k – $86k • 2 weeks ago
Elation Health • San Francisco • $190k – $270k • 2 weeks ago
Omada Health • San Francisco • $128k – $184k • 2 weeks ago
Ursa Space Systems • Ithaca • $160k – $170k • 2 weeks ago
